About Acera Surgical
Acera Surgical is a company based in St. Louis (United States) founded in 2013 was acquired by Solventum in November 2025. Acera Surgical has raised $6.32 million across 5 funding rounds from investors including Solventum, St. Louis Arch Angels and Missouri Technology. Acera Surgical offers products and services including Restrata Sheet, Restrata Meshed 2:1, Restrata MiniMatrix, and Cerafix. Acera Surgical operates in a competitive market with competitors including Adocia, Imbed Biosciences, Humacyte, Organogenesis and Sofregen, among others.
- Headquarter St. Louis, United States
-
Sectors
TechnologyAerospace, Defense & Maritime Healthcare Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Acera Surgical, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acera Surgical
Acera Surgical offers a comprehensive portfolio of products and services, including Restrata Sheet, Restrata Meshed 2:1, Restrata MiniMatrix, and Cerafix.
Engineered for soft tissue repair in refractory wounds.
Expandable matrix for surgical site coverage.
Dispersible for irregular tissue areas.
Implantable for dural closure and restoration.
People of Acera Surgical
Unlock access to complete
Unlock access to complete
Funding Insights of Acera Surgical
Acera Surgical has successfully raised a total of $6.32M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $5.12 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Acera Surgical
Acera Surgical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Solventum, St. Louis Arch Angels and Missouri Technology.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage businesses are funded by St. Louis Arch Angels.
|
Locked | Locked | Locked | |
|
Tech companies focused VC firm operating across Missouri
|
Locked | Locked | Locked | |
|
Innovative medical products and education services are developed and manufactured.
|
Locked | Locked | Locked |
Investor details for Acera Surgical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acera Surgical
Investment portfolio details for Acera Surgical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Acera Surgical
Detailed financials for Acera Surgical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Acera Surgical Comparisons
Peer comparison for Acera Surgical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Acera Surgical
Acera Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Imbed Biosciences, Humacyte, Organogenesis and Sofregen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Human tissue-based products are developed for vascular disease applications.
|
|
| Locked | Locked | Locked |
Regenerative therapies for wound care are developed and commercialized.
|
|
| Locked | Locked | Locked |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| Locked | Locked | Locked |
Personalized skin tissue therapy is developed by CUTISS for surgeries.
|
Detailed competitors of Acera Surgical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Acera Surgical
Complete news archive for Acera Surgical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acera Surgical
Acera Surgical was founded in 2013.
Acera Surgical is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Acera Surgical is a funded company, having raised a total of $6.32M across 5 funding rounds to date.
Acera Surgical was founded in 2013 in St. Louis, United States, and operates in the regenerative medicine sector. Synthetic biocompatible scaffolds are developed by the company for wound protection and tissue regeneration, featuring porous, fibrous structures made from absorbable polymers. Products include a pliable matrix for tensionless sutures and a sterile covering for defects. FDA clearance has been obtained for these offerings, supporting clinical applications in medical settings.
Acera Surgical's top competitors include Humacyte, Imbed Biosciences and Adocia.
Acera Surgical offers Restrata Sheet, Restrata Meshed 2:1, Restrata MiniMatrix, and Cerafix.
Acera Surgical has 3 investors. Key investors include Solventum, St. Louis Arch Angels, and Missouri Technology.